Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
November 3, 2023
Tags:
Stacy Burns-Guydish and Gary Henderson of List Labs consider recent innovations and challenges in the field of microbiome-based therapies and explain how CDMOs with experience in the production of live biotherapeutic products (LBPs) will play a key role in enabling realization of the full potential of this emerging field.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
